Hayakawa F - Search Results

1

Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.

Shinohara H, Taniguchi K, Kumazaki M, Yamada N, Ito Y, Otsuki Y, Uno B, Hayakawa F, Minami Y, Naoe T, Akao Y. Shinohara H, et al. Among authors: hayakawa f. Cancer Lett. 2015 Apr 28;360(1):28-38. doi: 10.1016/j.canlet.2015.01.039. Epub 2015 Jan 30. Cancer Lett. 2015. PMID: 25644089

2

Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.

Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T, Saito H. Hayakawa F, et al. Br J Haematol. 1998 Jun;101(3):521-8. doi: 10.1046/j.1365-2141.1998.00720.x. Br J Haematol. 1998. PMID: 9633897 Free article.

3

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines.

Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H, Naoe T. Hayakawa F, et al. Oncogene. 2000 Feb 3;19(5):624-31. doi: 10.1038/sj.onc.1203354. Oncogene. 2000. PMID: 10698507

4

Establishment of a stroma-dependent human acute myelomonocytic leukemia cell line, NAMO-2, with FLT3 tandem duplication.

Abe A, Kiyoi H, Ninomiya M, Yamazaki T, Murase T, Ozeki K, Suzuki M, Hayakawa F, Katsumi A, Emi N, Naoe T. Abe A, et al. Among authors: hayakawa f. Int J Hematol. 2006 Nov;84(4):328-36. doi: 10.1532/IJH97.06056. Int J Hematol. 2006. PMID: 17118759

5

SFK-STAT pathway: an alternative and important way to malignancies.

Hayakawa F, Naoe T. Hayakawa F, et al. Ann N Y Acad Sci. 2006 Nov;1086:213-22. doi: 10.1196/annals.1377.002. Ann N Y Acad Sci. 2006. PMID: 17185518 Review.

6

Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.

Okamoto M, Hayakawa F, Miyata Y, Watamoto K, Emi N, Abe A, Kiyoi H, Towatari M, Naoe T. Okamoto M, et al. Among authors: hayakawa f. Leukemia. 2007 Mar;21(3):403-10. doi: 10.1038/sj.leu.2404547. Epub 2007 Jan 18. Leukemia. 2007. PMID: 17230226

7

LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22).

Imagama S, Abe A, Suzuki M, Hayakawa F, Katsumi A, Emi N, Kiyoi H, Naoe T. Imagama S, et al. Among authors: hayakawa f. Eur J Haematol. 2007 Jul;79(1):25-31. doi: 10.1111/j.1600-0609.2007.00858.x. Epub 2007 May 28. Eur J Haematol. 2007. PMID: 17532767

8

Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis.

Hayakawa F, Abe A, Kitabayashi I, Pandolfi PP, Naoe T. Hayakawa F, et al. J Biol Chem. 2008 Sep 5;283(36):24420-5. doi: 10.1074/jbc.M802217200. Epub 2008 Jul 11. J Biol Chem. 2008. PMID: 18621739 Free PMC article.

9

Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.

Abe A, Minami Y, Hayakawa F, Kitamura K, Nomura Y, Murata M, Katsumi A, Kiyoi H, Jamieson CHM, Wang JYJ, Naoe T. Abe A, et al. Among authors: hayakawa f. Int J Hematol. 2008 Dec;88(5):471-475. doi: 10.1007/s12185-008-0221-1. Epub 2008 Nov 29. Int J Hematol. 2008. PMID: 19039626 Free PMC article.

10

BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.

Suzuki M, Abe A, Imagama S, Nomura Y, Tanizaki R, Minami Y, Hayakawa F, Ito Y, Katsumi A, Yamamoto K, Emi N, Kiyoi H, Naoe T. Suzuki M, et al. Among authors: hayakawa f. Eur J Haematol. 2010 Mar;84(3):229-38. doi: 10.1111/j.1600-0609.2009.01387.x. Epub 2009 Nov 28. Eur J Haematol. 2010. PMID: 20002159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters